Dopamine, morphine, and nitric oxide: An evolutionary signaling triad

CNS Neuroscience and Therapeutics

Volumn 16, Issue 3, 2010, Pages

  Stefano, George B ^a   Kream, Richard M ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alzheimer's disease; Dopamine; Morphine; Movement disorders Parkinson's disease; Neuropsychopharmacology; Nitric oxide

Indexed keywords

CALCIUM CHANNEL; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2D6; DOPAMINE; LEVODOPA; MORPHINE; NITRIC OXIDE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TYRAMINE; TYROSINE;

AMINO ACID METABOLISM; BIOSYNTHESIS; DOPAMINE METABOLISM; DOWN REGULATION; ENZYME RELEASE; ENZYME STRUCTURE; ENZYME SYNTHESIS; EVOLUTIONARY ADAPTATION; EXCITABILITY; HOMEOSTASIS; HORMONE ACTION; LETHALITY; LIGAND BINDING; NEUROTRANSMISSION; NONHUMAN; OXYGEN CONSUMPTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; EVOLUTION; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; DOPAMINE; EVOLUTION; HUMANS; MORPHINE; NITRIC OXIDE; SIGNAL TRANSDUCTION; BIOLOGICAL EVOLUTION;

EID: 77952131625     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2009.00114.x     Document Type: Review

References (164)

1. Kream RM, Stefano GB. De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit 2006 12 : RA207 RA219.
2. Stefano GB, Kream RM. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). Int J Mol Med 2007 20 : 837 841.
3. Giulivi C, Kato K, Cooper CE. Nitric oxide regulation of mitochondrial oxygen consumption I: Cellular physiology. Am J Physiol Cell Physiol 2006 291 : C1225 C1231. (Pubitemid 44878593)
4. Gorren AC, de Boer E, Wever R. The reaction of nitric oxide with copper proteins and the photodissociation of copper-NO complexes. Biochim Biophys Acta 1987 916 : 38 47.
5. Madsen L, Garras A, Asins G, Serra D, Hegardt FG, Berge RK. Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. Biochem Pharmacol 1999 57 : 1011 1019. (Pubitemid 29168549)
6. Engelman DT, Watanabe M, Maulik N, et al. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg 1995 60 : 1275 1281.
7. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994 23 : 1121 1131. (Pubitemid 24180877)
8. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987 138 : 550 565. (Pubitemid 17002220)
9. Bird DA, Facchini PJ. Berberine bridge enzyme, a key branch-point enzyme in benzylisoquinoline alkaloid biosynthesis, contains a vacuolar sorting determinant. Planta 2001 213 : 888 897.
10. Facchini PJ, De LV. Differential and tissue-specific expression of a gene family for tyrosine/dopa decarboxylase in opium poppy. J Biol Chem 1994 269 : 26684 26690.
11. Facchini PJ, Park SU. Developmental and inducible accumulation of gene transcripts involved in alkaloid biosynthesis in opium poppy. Phytochemistry 2003 64 : 177 186.
12. Facchini PJ, De LV. Expression in Escherichia coli and partial characterization of two tyrosine/dopa decarboxylases from opium poppy. Phytochemistry 1995 38 : 1119 1126.
13. Park SU, Johnson AG, Penzes-Yost C, Facchini PJ. Analysis of promoters from tyrosine/dihydroxyphenylalanine decarboxylase and berberine bridge enzyme genes involved in benzylisoquinoline alkaloid biosynthesis in opium poppy. Plant Mol Biol 1999 40 : 121 131. (Pubitemid 29300733)
14. Samanani N, Facchini PJ. Isolation and partial characterization of norcoclaurine synthase, the first committed step in benzylisoquinoline biosynthesis, from poppy. Planta 2001 213 : 898 906. (Pubitemid 32996959)
15. Samanani N, Facchini PJ. Purification and characterization of norcoclaurine synthase. The first committed enzyme in benzylisoquinoline alkaloid biosynthesis in plants. J Biol Chem 2002 277 : 33878 33883.
16. De-Eknamkul W, Zenk MH. Enzymatic formation of (R)-reticuline from 1,2-dehydroreticuline in the opium poppy plant. Tetrahedron Lett 1990 31 : 4855 4858. (Pubitemid 20251227)
17. Frenzel T, Zenk MH. S-Adenosyl-L-methionine: 3'-hydroxy-N-methyl-(S)- coclaurine 4'-O-methyltransferase, a regio- and stereoselective enzyme of the (S)-reticuline pathway. Phytochemistry 1990 29 : 3505 3511.
18. Gerady R, Zenk MH. Formation of salutaridine from (R)-reticuline by a membrane-bound cytochrome P-450 enzyme from Papaver somniferum. Phytochemistry 1992 32 : 79 86.
19. Herbert RB. The biosynthesis of isoquinoline alkaloids. In : Phillipson JD, Roberts MF, Zenk MH, eds. The Chemistry and Biology of Isoquinoline Alkaloids.
20. Lenz R, Zenk MH. Closure of the oxide bridge in morphine biosynthesis. Tetrahedron Lett 1994 35 : 3897 3900. (Pubitemid 24199602)
21. Lenz R, Zenk MH. Stereospecific reduction of codeinone, the penultimate enzymatic step during morphine biosynthesis in Papaver somniferum. Tetrahedron Lett 1995 36 : 2449 2452.
22. Lenz R, Zenk MH. Purification and properties of codeinone reductase (NADPH) from Papaver somniferum cell cultures. Eur J Biochem 1995 233 : 132 139.
23. Loeffler S, Zenk MH. The hydroxylation step in the biosynthesis pathway leading from norcoclaurine to reticuline. Phytochemistry 1990 29 : 3499 3503.
24. Zhu W, Ma Y, Bell A, et al. Presence of morphine in rat amygdala: Evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit 2004 10 : BR433 BR439. (Pubitemid 40268549)
25. Zhu W, Mantione KJ, Shen L, Stefano GB. In vivo and in vitro L-DOPA exposure increases ganglionic morphine levels. Med Sci Monit 2005 11 : MS1 MS5. (Pubitemid 40790943)
26. Zhu W, Mantione KJ, Shen L, et al. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit 2005 11 : BR397 BR404. (Pubitemid 41695480)
27. Zhu W, Cadet P, Baggerman G, Mantione KJ, Stefano GB. Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol 2005 175 : 7357 7362. (Pubitemid 41713432)
28. Boettcher C, Fellermeier M, Boettcher C, Drager B, Zenk MH. How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA 2005 102 : 8495 8500. (Pubitemid 40862764)
29. Stefano GB, Aiello E. Histoflourescent localization of serotonin and dopamine in the nervous system and gill of Mytilus edulis (Bivalvia). Biol Bull 1975 148 : 141 156.
30. Stefano GB, Catapane EJ, Aiello E. Dopaminergic agents: Influence on serotonin in the molluscan nervous system. Science 1976 194 : 539 541.
31. Stefano GB. Comparative aspects of opioid-dopamine interaction. Cell Mol Neurobiol 1982 2 : 167 178.
32. Stefano GB. Norepinephrine: Presence and interaction with endogenous biogenic amines. In : Stefano GB, ed. Neurobiology of Mytilus edulis.
33. Iversen LL, Iversen SD, Snyder SH. Biochemistry of biogenic amines.
34. Stefano GB, Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 1994 4 : 57 68.
35. Stefano GB. Autoimmunovascular regulation: Morphine and anandamide stimulated nitric oxide release. J Neuroimmunol 1998 83 : 70 76.
36. Stefano GB, Goumon Y, Bilfinger TV, Welters I, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Prog Neurobiol 2000 60 : 513 530.
37. Stefano GB, Goumon Y, Casares F, et al. Endogenous morphine. Trends Neuroscie 2000 9 : 436 442.
38. Stefano GB, Fricchione GL. The biology of deception: The evolution of cognitive coping as a denial-like process. Med Hypotheses 1995 44 : 311 314.
39. Stefano GB, Fricchione GL. The biology of deception: Emotion and morphine. Med Hypotheses 1995 49 : 51 54.
40. Gintzler AR, Levy A, Spector S. Antibodies as a means of isolating and characterizing biologically active substances: Presence of a non-peptide morphine-like compound in the central nervous system. Proc Natl Acad Sci USA 1976 73 : 2132 2136.
41. Gintzler AR, Gershon MD, Spector S. A nonpeptide morphine-like compound: Immunocytochemical localization in the mouse brain. Science 1978 199 : 447 448.
42. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A. Endogenous codeine and morphine are stored in specific brain neurons. Brain Res 1993 627 : 210 215.
43. Bianchi E, Guarna M, Tagliamonte A. Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol 1994 4 : 83 92.
44. Sonetti D, Mola L, Casares F, Bianchi E, Guarna M, Stefano GB. Endogenous morphine levels increase in molluscan neural and immune tissues after physical trauma. Brain Res 1999 835 : 137 147.
45. Sonetti D, Peruzzi E, Stefano GB. Endogenous morphine and ACTH association in neural tissues. Med Sci Monit 2005 11 : MS22 MS30.
46. Donnerer J, Oka K, Brossi A, Rice KC, Spector S. Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci USA 1986 83 : 4566 4567.
47. Kodaira H, Spector S. Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proc Natl Acad Sci USA 1988 85 : 1267 1271.
48. Goldstein A, Barrett RW, James IF, Lowney LI, Weitz C, Knipmeyer LI, Rapoport H. Morphine and other opiates from beef brain and adrenal. Proc Natl Acad Sci USA 1985 82 : 5203 5207.
49. Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. Morphine and codeine from mammalian brain. Proc Natl Acad Sci USA 1986 83 : 9784 9788.
50. Weitz CJ, Faull KF, Goldstein A. Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature 1987 330 : 674 677.
51. Amann T, Zenk MH. Formation of the morphine precursor salutaridine is catalyzed by a cytochrome P-450 enzyme mammalian liver. Tetrahedron Lett 1991 32 : 3675 3678.
52. Amann T, Roos PH, Huh H, Zenk MH. Purification and characterization of a cytochrome P450 enzyme from pig liver, catalyzing the phenol oxidative coupling of (R)-reticuline to salutaridine, the critical step in morphine biosynthesis. Heterocycles 1995 40 : 425 440.
53. Sango K, Maruyama W, Matsubara K, Dostert P, Minami C, Kawai M, Naoi M. Enantio-selective occurrence of (S)-tetrahydropapaveroline in human brain. Neurosci Lett 2000 283 : 224 226.
54. Davis VE, Walsh MJ, Yamanaka Y. Augmentation of alkaloid formation from dopamine by alcohol and acetaldehyde in vitro. J Pharmacol Exp Ther 1970 174 : 401 412.
55. Yamanaka Y, Walsh MJ, Davis VE. Salsolinol, an alkaloid derivative of dopamine formed in vitro during alcohol metabolism. Nature 1970 227 : 1143 1144.
56. Turner AJ, Baker KM, Algeri S, Erigerio A, Garattini S. Tetrahydropapaveroline: Formation in vivo and in vitro in rat brain. Life Sci 1974 14 : 2247 2257.
57. Sandler M, Glover V, Armando I, Clow A. Pictet-Spengler condensation products, stress and alcoholism: Some clinical overtones. Prog Clin Biol Res 1982 90 : 215 226.
58. Naoi M, Maruyama W, Nagy GM. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains. Neurotoxicology 2004 25 : 193 204.
59. Niwa T, Maruyama W, Nakahara D, et al. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry. J Chromatogr 1992 578 : 109 115.
60. Poeaknapo C, Schmidt J, Brandsch M, Drager B, Zenk MH. Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 2004 101 : 14091 14096.
61. Boettcher C, Fellermeier M, Boettcher C, Drager B, Zenk MH. How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA 2005 102 : 8495 8500.
62. Zhu W, Mantione KJ, Shen L, Lee B, Stefano GB. Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: Nicotine addiction. Cell Mol Neurobiol 2006 26 : 1037 1045.
63. Lind AB, Wadelius M, Darj E, Finnstrom N, Lundgren S, Rane A. Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol Toxicol 2003 92 : 295 299.
64. Hiroi T, Imaoka S, Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun 1998 249 : 838 843.
65. Zhu W, Mantione KJ, Casares FM, et al. Alcohol-, nicotine-, and cocaine-evoked release of morphine from invertebrate ganglia: Model system for screening drugs of abuse. Med Sci Monit 2006 12 : BR155 BR161.
66. Zhu W, Mantione KJ, Casares FM, Sheehan MH, Kream RM, Stefano GB. Cholinergic regulation of endogenous morphine release from lobster nerve cord. Med Sci Monit 2006 12 : BR295 BR301.
67. Zhu W, Mantione K, Kream RM, Stefano GB. Alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: Substances of abuse actions converge on endogenous morphine release. Med Sci Monit 2006 12 : BR350 BR354.
68. Stefano GB, Bianchi E, Guarna M, et al. Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: The dopamine-morphine hypothesis. Med Sci Monit 2007 13 : RA91 RA102.
69. Stefano GB, Scharrer B, Smith EM, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996 16 : 109 144.
70. Stefano GB, Liu Y. Opiate antagonism of opioid actions on immunocyte activation and nitric oxide release. Anim Biol 1996 1 : 11 16.
71. Pryor SC, Zhu W, Cadet P, Bianchi E, Guarna M, Stefano GB. Endogenous morphine: Opening new doors for the treatment of pain and addiction. Expert Opin Biol Ther 2005 5 : 893 906.
72. Moncada S, Higgs A, Furchgott R. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 1997 49 : 137 142.
73. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991 41 : 485 490.
74. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991 43 : 109 142.
75. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Eng J Med 1993 329 : 2002 2012.
76. Moncada S. Nitric oxide in the vasculature: Physiology and pathophysiology. Ann N Y Acad Sci 1997 811 : 60 67.
77. Fimiani C, Liberty T, Aquirre AJ, Amin I, Ali N, Stefano GB. Opiate, cannabinoid, and eicosanoid signaling converges on common intracellular pathways: Nitric oxide coupling. Prostaglandins Other Lipid Mediat 1999 57 : 23 34.
78. Welters ID, Fimiani C, Bilfinger TV, Stefano GB. NF-kB, nitric oxide and opiate signaling. Med Hypotheses 1999 54 : 263 268.
79. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB. Tonal nitric oxide and health: A free radical and a scavenger of free radicals. Med Sci Monit 2002 8 : 1 4.
80. Esch T, Stefano GB, Fricchione GL, Benson H. Stress-related diseases: A potential role for nitric oxide. Med Sci Monit 2002 8 : RA103 RA118.
81. Stefano GB, Esch T. Integrative medical therapy: Examination of meditation's therapeutic and global medicinal outcomes via nitric oxide (review). Int J Mol Med 2005 16 : 621 630.
82. Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006 12 : 1269 1277.
83. Xu Q, Wink DA, Colton CA. Nitric oxide production and regulation of neuronal NOS in tyrosine hydroxylase containing neurons. Exp Neurol 2004 188 : 341 350.
84. Kato K, Giulivi C. Critical overview of mitochondrial nitric-oxide synthase. Front Biosci 2006 11 : 2725 2738.
85. Riobo NA, Melani M, Sanjuan N, et al. The modulation of mitochondrial nitric-oxide synthase activity in rat brain development. J Biol Chem 2002 277 : 42447 42455.
86. Stefano GB, Digenis A, Spector S, et al. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA 1993 90 : 11099 11103.
87. Cadet P, Mantione KJ, Stefano GB. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 2003 170 : 5118 5123.
88. Kream RM, Sheehan M, Cadet P, Mantione KJ, Zhu W, Casares FM, Stefano GB. Persistence of evolutionary memory: Primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit 2007 13 : SC5 SC6.
89. Cadet P, Mantione KJ, Zhu W, Kream RM, Sheehan M, Stefano GB. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol 2007 179 : 5839 5844.
90. Kotturi MF, Hunt SV, Jefferies WA. Roles of CRAC and Cav-like channels in T cells: More than one gatekeeper? Trends Pharmacol Sci 2006 27 : 360 367.
91. Bozarth MA. Pleasure systems in the brain. In : Wartburton DM, ed. Pleasure: The politics and the reality.
92. Nestler EJ, Malenka RC. The addicted brain. Sci Am 2004 290 : 78 85.
93. Stefano GB, Fricchione GL, Slingsby BT, Benson H. The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Res: Brain Res Rev 2001 35 : 1 19.
94. Hui KKS, Liu J, Makris N, et al. Acupuncture modulates the limbic system and subcortical gray structures of the human brain: Evidence from fMRI studies in normal subjects. Hum Brain Mapp 2000 9 : 13 25.
95. Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinol Lett 2002 23 : 199 208.
96. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999 3 : 11 21.
97. Esch T. Music medicine: Music in association with harm and healing. Musikphysiol Musikermed 2003 10 : 213 224.
98. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001 2 : 119 128.
99. Nestler EJ, Malenka RC, Hyman SE. Molecular basis of neuropharmacology.
100. Guarna M, Bianchi E, Bartolini A, et al. Endogenous morphine modulates acute thermonociception in mice. J Neurochem 2002 80 : 271 277.
101. Rodriguez DF, Navarro M. Role of the limbic system in dependence on drugs. Ann Med 1998 30 : 397 405.
102. Weiss F, Koob GF. Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotox Res 2001 3 : 145 156.
103. Esch T, Stefano GB. The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinol Lett 2004 25 : 235 251.
104. Bozarth MA. Ventral tegmental reward system. In : Oreland L, Engel J, eds. Brain reward systems and abuse.
105. Mitchell JB, Stewart J. Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates. Pharmacol Biochem Behav 1990 35 : 643 650.
106. Hamilton ME, Bozarth MA. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats. Life Sci 1988 43 : 941 946.
107. Heath RG. Pleasure response of human subjects to direct stimulation of the brain. In : Heath RG, ed. The role of pleasure in human behavior.
108. Stefano GB, Scharrer B, Bilfinger TV, Salzet M, Fricchione GL. A novel view of opiate tolerance. Adv Neuroimmunol 1996 6 : 265 277.
109. McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 2003 6 : 1208 1215.
110. Zhang L, Lou D, Jiao H, et al. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 2004 24 : 3344 3354.
111. Murphy CA, Russig H, Pezze MA, Ferger B, Feldon J. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: Effects of different schedules of administration. Neuropharmacology 2003 44 : 926 939.
112. Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction 2001 96 : 103 114.
113. Bozarth MA. New perspectives on cocaine addiction: Recent findings from animal research. Can J Physiol Pharmacol 1989 67 : 1158 1167.
114. Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992 221 : 227 234.
115. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987 94 : 469 492.
116. Thompson AC, Kristal MB. Opioids in the ventral tegmental area facilitate the onset of maternal behavior in the rat. Soc Neurosci Abstr 1992 18 : 539.
117. Esch T, Guarna M, Bianchi E, Zhu W, Stefano GB. Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit 2004 10 : MS6 MS17.
118. Esch T, Stefano GB. The neurobiology of love. Neuroendocrinol Lett 2005 26 : 175 192.
119. Salamon E, Esch T, Stefano GB. The role of the amygdala in mediating sexual and emotional behavior via coupled nitric oxide release. Acta Pharmacologica Sinica 2005 26 : 389 395.
120. Stefano GB, Fricchione GL, Esch T. Relaxation: Molecular and physiological significance. Med Sci Monit 2006 12 : HY21 HY31.
121. Davis VE, Walsh MJ. Alcohol, amines, and alkaloids: A possible biochemical basis for alcohol addiction. Science 1970 167 : 1005 1007.
122. Halushka PV, Hoffmann PC, Davis VE, Walsh MJ. Alcohol addiction and tetrahydropapaveroline. Science 1970 169 : 1104 1106.
123. Walsh MJ, Davis VE, Yamanaka Y. Tetrahydropapaveroline: An alkaloid metabolite of dopamine in vitro. J Pharmacol Exp Ther 1970 174 : 388 400.
124. Weiner H. Relationship between 3,4-dihydroxyphenylacetaldehyde levels and tetrahydropapaveroline formation. Alcohol Clin Exp Res 1978 2 : 127 131.
125. Collins MA, Hannigan JJ, Weiner C. Effects of catecholic tetrahydroisoquinolines on endogenous catecholamines. Curr Alcohol 1979 5 : 53 59.
126. Weiner H. Possible steady-state concentrations of tetrahydroisoquinolines in brain after the consumption of ethanol. Fed Proc 1981 40 : 2082 2085.
127. Clow A, Stolerman IP, Murray RM, Sandler M. Ethanol preference in rats: Increased consumption after intraventricular administration of tetrahydropapaveroline. Neuropharmacology 1983 22 : 563 565.
128. Myers RD. Anatomical "circuitry" in the brain mediating alcohol drinking revealed by THP-reactive sites in the limbic system. Alcohol 1990 7 : 449 459.
129. Duncan CC, Fernando PW. Effects of tetrahydropapaveroline in the nucleus accumbens and the ventral tegmental area on ethanol preference in the rat. Alcohol 1991 8 : 87 90.
130. Myers RD, Robinson DE. Tetrahydropapaveroline injected in the ventral tegmental area shifts dopamine efflux differentially in the shell and core of nucleus accumbens in high-ethanol-preferring (HEP) rats. Alcohol 1999 18 : 83 90.
131. Sallstrom BS, Hill R, Kiianmaa K, Rommelspacher H. Effect of ethanol on (R)- and (S)-salsolinol, salsoline, and THP in the nucleus accumbens of AA and ANA rats. Alcohol 1999 18 : 165 169.
132. Shearman GT, Herz A. Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects. Psychopharmacology (Berl) 1983 81 : 224 227.
133. Haber H, Roske I, Rottmann M, Georgi M, Melzig MF. Alcohol induces formation of morphine precursors in the striatum of rats. Life Sci 1997 60 : 79 89.
134. McCoy JG, Strawbridge C, McMurtrey KD, Kane VB, Ward CP. A re-evaluation of the role of tetrahydropapaveroline in ethanol consumption in rats. Brain Res Bull 2003 60 : 59 65.
135. Heikkila R, Cohen G, Dembiec D. Tetrahydroisoquinoline alkaloids: Uptake by rat brain homogenates and inhibition of catecholamine uptake. J Pharmacol Exp Ther 1971 179 : 250 258.
136. Greenberg RS, Cohen G. Tetrahydroisoquinoline alkaloids: Stimulated secretion from the adrenal medulla. J Pharmacol Exp Ther 1973 184 : 119 128.
137. Katz S, Cohen G. A comparison of 6,7-dihydroxytetrahydroisoquinoline, salsolinol and tetrahydropapaveroline as inhibitors of monoamine oxidase within the adrenergic nerve plexus of the isolated mouse atrium. Res Commun Chem Pathol Pharmacol 1976 13 : 217 224.
138. Britton DR. A convergent approach to the pharmacology of tetrahydroisoquinolines. Prog Clin Biol Res 1982 90 : 321 326.
139. Suzuki K, Mizuno Y, Yoshida M. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain. Neurochem Res 1990 15 : 705 710.
140. Naoi M, Maruyama W, Kasamatsu T, Dostert P. Oxidation of N-methyl(R)salsolinol: Involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines. J Neural Transm Suppl 1998 52 : 125 138.
141. Collins MA. Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler. Neurotoxicology 2004 25 : 117 120.
142. Johnston GA. L-dopa and pyridoxal 5'-phosphate: Tetrahydroisoquinoline formation. Lancet 1971 297 : 1068.
143. Sandler M, Carter SB, Hunter KR, Stern GM. Tetrahydroisoquinoline alkaloids: In vivo metabolites of L-dopa in man. Nature 1973 241 : 439 443.
144. Davis VE, Cashaw JL, McMurtrey KD. Disposition of catecholamine-derived alkaloids in mammalian systems. Adv Exp Med Biol 1975 59 : 65 78.
145. Coscia CJ, Burke W, Jamroz G, et al. Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopa-treated parkinsonian patients. Nature 1977 269 : 617 619.
146. Matsubara K, Fukushima S, Akane A, Kobayashi S, Shiono H. Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: A possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans. J Pharmacol Exp Ther 1992 260 : 974 978.
147. Galloway MP, Burke WJ, Coscia CJ. Tetrahydroisoquinolinecarboxylic acids and catecholamine metabolism in adrenal medulla explants. Biochem Pharmacol 1982 31 : 3251 3256.
148. Nimit Y, Schulze I, Cashaw JL, Ruchirawat S, Davis VE. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. J Neurosci Res 1983 10 : 175 189.
149. Okada T, Shimada S, Sato K, et al. Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells. Neurosci Res 1998 30 : 87 90.
150. Soh Y, Shin MH, Lee JS, Jang JH, Kim OH, Kang H, Surh YJ. Oxidative DNA damage and glioma cell death induced by tetrahydropapaveroline. Mutat Res 2003 544 : 129 142.
151. Shin MH, Jang JH, Surh YJ. Potential roles of NF-kappaB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline. Free Radic Biol Med 2004 36 : 1185 1194.
152. Kim YM, Kim MN, Lee JJ, Lee MK. Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci Lett 2005 386 : 1 4.
153. Cadet P, Zhu W, Mantione K, et al. Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int J Mol Med 2003 12 : 485 492.
154. Fricchione GL, Stefano GB. Placebo neural systems: Nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit 2005 11 : MS54 MS65.
155. Berg D, Becker G, Reiners K. Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica. J Neural Transm 1999 106 : 725 728.
156. Berg D, Becker G, Naumann M, Reiners K. Morphine in tardive and idiopathic dystonia (short communication). J Neural Transm 2001 108 : 1035 1041.
157. Stefano GB, Fricchione GL, Goumon Y, Esch T. Pain, immunity, opiate and opioid compounds and health. Med Sci Monit 2005 11 : MS47 MS53.
158. Esch T, Kim JW, Stefano GB. Neurobiological implications of eating healthy. Neuro Endocrinol Lett 2006 27 : 21 33.
159. Stefano GB, Leung MK, Bilfinger TV, Scharrer B. Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules. J Neuroimmunol 1995 63 : 175 181.
160. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS. Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation. J Biol Chem 1995 270 : 30290 30293.
161. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995 270 : 30290 30293.
162. Mantione KJ, Cadet P, Zhu W, et al. Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: Autocrine/paracrine feedback inhibition. Addict Biol 2008 13 : 118 123.
163. Stefano GB, Kream RM, Mantione KJ, et al. Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: Implications for cancer biology. Semin Cancer Biol 2008 18 : 199 210.
164. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB. Tonal nitric oxide and health: Anti-bacterial and -viral actions and implications for HIV. Med Sci Monit 2002 8 : RA27 RA31.